BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, today announced the launch of Sandman AllianceSM, a first-of-its-kind sleep therapy management program. The Sandman Alliance program is the latest addition to Covidien’s “Unite to Treat Sleep Apnea” initiative to improve the diagnosis and treatment of sleep disorders.
